1. Prepandemic Influenza Vaccine H5N1 (Split Virion, Inactivated, Adjuvanted) [Prepandrix™]

   • Natalie J. Carter
   • Greg L. Plosker

   Adis Drug Evaluation 13 August 2012 Pages: 279 - 292

   

2. Application of Glatiramer Acetate to Neurodegenerative Diseases beyond Multiple Sclerosis

   • Michal Schwartz
   • Shay Bukshpan
   • Gilad Kurds

   Current Opinion 13 August 2012 Pages: 293 - 299

   

3. Recombinant Antibodies as Therapeutic Agents

   • Frederico Aires da Silva
   • Sofia Corte-Real
   • Joao Goncalves

   Drug Development 13 August 2012 Pages: 301 - 314

   

4. The Impact of PEGylation on Biological Therapies

   • Francesco M. Veronese
   • Anna Mero

   Drug Development 13 August 2012 Pages: 315 - 329

   

5. A PEGylated Fab’ Fragment against Tumor Necrosis Factor for the Treatment of Crohn Disease

   • Tim Bourne
   • Gianluca Fossati
   • Andrew Nesbitt

   Drug Development 13 August 2012 Pages: 331 - 337

   

6. Spotlight on Bevacizumab in Metastatic Colorectal Cancel

   • Paul L. McCormack
   • Susan J. Keam

   Apis Spotlight 13 August 2012 Pages: 339 - 341

7. Spotlight on Enoxaparin in ST-Segment Elevation Myocardial Infarction

   • Natalie J. Carter
   • Paul L. McCormack
   • Greg L. Plosker

   Adis Spotlight 13 August 2012 Pages: 343 - 345